Topical GHK-Cu vs injectable GHK-Cu: when to use which format
Injectable GHK-Cu delivers the peptide systemically through subcutaneous injection. Topical GHK-Cu acts locally on the skin or scalp where applied. Both use the identical Gly-His-Lys-Cu tripeptide but target different tissues and different indications. This guide walks the mechanism overlap, the absorption differences, and which RxPepsDirect SKU fits which goal.
7 min read · Updated May 25, 2026
Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed May 25, 2026.The short answer
Both routes use the same Gly-His-Lys-Cu tripeptide molecule, but they reach different tissues at different concentrations. Topical GHK-Cu delivers a high local concentration to the skin or scalp where applied and is the standard of care for skin and hair indications. Injectable GHK-Cu delivers a systemic dose distributed across all tissues and is the standard of care for recovery, wound healing, and longevity indications. The two are mechanistically compatible and can be stacked.
Side-by-side comparison
| Topical GHK-Cu | Injectable GHK-Cu | |
|---|---|---|
| Molecule | Identical (Gly-His-Lys-Cu) | Identical (Gly-His-Lys-Cu) |
| Route | Cream, serum, or scalp solution | Subcutaneous injection |
| Distribution | Local (application site) | Systemic (all tissues) |
| Active concentration | 1 to 3 percent at application site | 10 mg/mL in injectable vehicle |
| Standard indication | Skin aging, hair restoration | Recovery, wound healing, longevity |
| Response timeline | 8 to 12 weeks visible | Depends on indication (weeks to months) |
| Side effects | Mild local irritation (transient) | Injection-site reaction; the copper uglies titration phase |
| Provider visit | $39 telehealth | $39 telehealth |
| RxPepsDirect price | $45 to $140 per 30-day supply | $80 per 10mg vial |
The shared mechanism
GHK-Cu is the copper-bound tripeptide glycyl-histidyl-lysyl copper. Whether it arrives in skin via a cream or via plasma after injection, it binds the same receptors and triggers the same signaling cascades:
- Fibroblast signaling: upregulation of collagen, elastin, and proteoglycan synthesis genes.
- Antioxidant induction: SOD2 and other endogenous antioxidant enzymes are upregulated.
- Wound and barrier repair: faster re-epithelialization and stronger lipid barrier reconstruction.
- VEGF expression in dermal papilla cells: drives the follicular regrowth effect in scalp tissue.
The difference is dose and distribution. Topical delivers high local concentration to the dermis (the cells that matter for skin aging and hair). Injectable delivers systemic distribution to every tissue, with much lower per-tissue concentration.
When topical wins
For localized indications, topical is the more efficient route because it delivers a higher concentration directly to the target cells:
- Skin aging: Topical 3 percent GHK-Cu reaches dermal fibroblasts at concentrations injectable cannot match without much larger systemic doses.
- Hair restoration: Topical 1 percent GHK-Cu solution applied directly to the scalp delivers a higher local dose to dermal papilla cells than injectable distribution achieves.
- Barrier repair, post-procedural skin recovery: Local delivery is faster-acting and more targeted than systemic delivery.
Most cosmetic dermatology applications fall into this category. RxPepsDirect prescribes six topical formulations covering daily moisturizer (Cashmere Cream), mature-skin support (Biocosmetic), expression-line targeting (SNAP-8 combos), and hair restoration (the 1 percent scalp solution).
When injectable wins
For systemic indications, injectable is the more efficient route because the target tissues are deep, distributed, or not accessible via topical absorption:
- Tissue repair after injury or surgery: Systemic distribution reaches injury sites that topical cannot.
- Anti-inflammatory and immune-modulating use: Plasma levels matter more than local skin concentration.
- Longevity protocols: Systemic copper-peptide exposure supports antioxidant systems and SIRT1 pathway activity beyond the skin.
- Combined GHK-Cu plus other recovery peptides: Stack protocols (with BPC-157, TB-500, KPV) work systemically.
RxPepsDirect prescribes injectable GHK-Cu (10mg/mL, $80 / 5mL) under Recovery and Repair. See the deeper GHK-Cu protocol guide for the injectable evidence base and dosing.
Stacking topical and injectable
The two routes are mechanistically compatible and many patients run both:
- Topical 3 percent GHK-Cu cream daily for face. Plus injectable GHK-Cu twice weekly for systemic recovery support.
- Topical 1 percent scalp solution for hair restoration. Plus injectable GHK-Cu inside a BPC-157 or TB-500 recovery stack.
- Post-procedural protocol: short-course injectable around the procedure window, ongoing topical for sustained dermal support.
There is no documented antagonism. The two routes act additively at the shared receptor and signaling pathways.
The 503A pathway for both formats
Both topical and injectable GHK-Cu are compounded prescription products under FDA Section 503A. RxPepsDirect provides the telehealth prescription for both; Optimal Balance Pharmacy (Texas 503A) fills the prescription, ships direct to the patient via FedEx overnight, and collects payment at wholesale pricing. Provider screens for copper allergy, Wilson's disease, and contraindications during the same $39 visit regardless of format.
See Are peptides legal in the United States in 2026? for the full statutory chain and Topical GHK-Cu protocol guide for the topical-specific protocol.
Bottom line
Topical GHK-Cu and injectable GHK-Cu use the same molecule but deliver it to different tissues at different concentrations. Topical is the standard of care for skin and hair; injectable is the standard of care for systemic recovery, wound healing, and longevity. The two stack cleanly without documented antagonism. RxPepsDirect prescribes both formats through Optimal Balance Pharmacy with a single $39 telehealth visit covering whichever combination the provider recommends.
Continue reading